The company's second device to receive FDA approval will be marketed with GE Healthcare.
Medical device company Deep Breeze Ltd. has received FDA approval to market its lung imaging system in the US. The device can be used to measure breathing by the patient's bed in hospital intensive care units.
This device, which is radiation free and non-invasive, will be marketed with GE Healthcare, who are already marketing a similar imaging system developed by Deep Breeze, which is suitable for private clinics. Both devices are already being marketed in Europe and the Far East.
Published by Globes [online], Israel business news - www.globes-online.com - on December 17, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008